# Ampio Pharmaceuticals, Inc. (AMPE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AMPE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 264.9K | $ -9.33M | $ -9.26M | $ 274.0K | $ 3.36M |
| 2022 | $ 0 | $ -18.12M | $ -23.60M | $ 803.0K | $ 11.79M |
| 2021 | $ 0 | $ -20.30M | $ -16.75M | $ 925.0K | $ 27.28M |
| 2020 | $ 0 | $ -20.25M | $ -18.84M | $ 1.21M | $ 17.51M |
| 2019 | $ 574.2K | $ -17.59M | $ -19.88M | $ 1.47M | $ 6.44M |
| 2018 | $ 1.09M | $ 44.88M | $ -16.78M | $ 537.0K | $ 5.24M |
| 2017 | $ 1.20M | $ -69.91M | $ -15.47M | $ 0 | $ -34.18M |
| 2016 | $ 2.11M | $ -26.36M | $ -20.13M | $ 0 | $ 6.63M |
| 2015 | $ 1.63M | $ -44.65M | $ -37.46M | $ 4.92M | $ 37.00M |
| 2014 | $ 108.5K | $ -53.87M | $ -55.69M | $ 0 | $ 66.12M |
| 2013 | $ 71.1K | $ -34.15M | $ -29.55M | $ 0 | $ 33.08M |
| 2012 | $ 72.2K | $ -16.74M | $ -14.03M | $ 0 | $ 23.83M |
| 2011 | $ 27.5K | $ -26.97M | $ -13.42M | $ 0 | $ 17.76M |
| 2010 | $ 0 | $ -12.19M | $ -3.98M | $ 2.13M | $ -4.01M |
| 2009 | $ 0 | $ -1.42M | $ -32.4K | $ 200.0K | $ -69.9K |
| 2008 | $ 0 | $ -48.3K | $ -57.2K | $ 60.0K | $ -43.9K |
| 2007 | $ 0 | $ -48.4K | $ -27.8K | $ 20.0K | $ -12.0K |
| 2006 | $ 0 | $ -760 | $ -750 | $ 0 | $ 20.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.08 |
| Liabilities / Eq | 0.71 |
| Current Ratio | 2.41 |

## Other views

- [Metrics](https://sponda.capital/en/AMPE.md)
- [Charts](https://sponda.capital/en/AMPE/charts.md)
- [Compare](https://sponda.capital/en/AMPE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.